The global tissue engineering and biomaterial-based regenerative medicine market has entered a phase of rapid transformation, reflecting the increasing intersection of biotechnology, advanced materials, and clinical innovation. Valued at USD 584.96 million in 2024, the market is projected to grow at a compound annual growth rate of 31.3% between 2025 and 2034, underlining its role as one of the...